Science

Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.

Research & Development

Evidence

Clinical Trials

The Sepsis ImmunoScore® Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers

Read More →

Products

Prenosis is developing a pipeline of integrated diagnostics and therapeutics grounded in each patient's unique biological profile, using deep data science and AI to give clinicians tools that reflect the true complexity of critical disease.

Immunix®

Sepsis ImmunoScore®

BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease

Read More →

Resources

Blogs, articles, videos, and podcasts exploring how precision medicine and AI are changing the way clinicians detect and treat critical conditions.

Resource Library

Events

Treating the Patient, Not the Disease

Read More →

Newsroom

Read the latest Prenosis peer-reviewed articles and items from scholarly journals.

Newsroom

Sepsis ImmunoScore Outperforms Conventional Sepsis Tools

Read More →

About

As a biology-based technology company, we combine data science with AI to transform how critical conditions are diagnosed and treated.

Mission, Vision & Values

Careers

Leadership

Awards

LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection

Read More →

Clinical Trials

Testing what the body of research suggests: that a patient’s underlying biology, not a one-size-fits-all protocol, should guide their treatment.

Right Treatment. Right Patient.

Today, steroids are prescribed broadly for patients at risk of acute respiratory distress syndrome (ARDS), with little insight into which patients actually benefit and which don’t. Our clinical trials – conducted with leading academic research partners and supported in part by federal funding – are designed to answer that question directly, by tapping into individual patient biology to determine which patients will respond to which treatments, and training our models to recognize those patterns in future patients.

Going Further. Together.

Built with the Nation’s Leading Research Centers

Our trials run in partnership with Vanderbilt Coordinating Center and the STRIVE Network, a consortium of top academic research centers focused on respiratory disease. By integrating directly with hospital systems, our precision medicine platform helps sites quickly identify eligible patients and needed samples, making it easier for leading research centers to participate. The faster we learn, the faster we can turn what we learn into targeted therapies.

See People Differently

Successful Clinical Trials for Acute Illness

Clinical trials for acute conditions like sepsis, ARDS, and acute kidney injury have largely been unsuccessful. Until now. Prenosis has the biological map, combined with AI and machine learning tools, to select patients for individual, tailored trials. And with each new trial, our biobank expands, giving our precision medicine platform the data needed to help hospitals quickly identify eligible patients, manage samples, and participate in the next study.

Fulfilling the Vision of Healthcare Tailored to Biology

See how our clinical trials fit into a broader research strategy built on data, partnership, and rigorous validation.

Our R&D Strategy →

Proprietary Biobank and Dataset

Every trial adds to NOSIS, the biobank powering Immunix and sharpening our understanding of acute illness.

Explore the Biobank →

Validated by Peer-Reviewed Evidence

Explore the peer-reviewed research behind our approach to precision medicine in acute care.

Read Our Evidence →